Obesity has been linked with a host of metabolic and reproductive disorders including polycystic ovary syndrome (PCOS). While a clear association exists between obesity and PCOS, the exact nature of this relationship remains unexplained. The primary symptoms of PCOS include hyperandrogenism, anovulation, and polycystic ovaries. Most animal models utilize androgen treatments to induce PCOS. However, these models often fail to address the underlying causes of the disease and do not effectively reproduce key metabolic features such as hyperinsulinemia. Here, we present a novel rodent model of diet-induced obesity that recapitulates both the metabolic and reproductive phenotypes of human PCOS. Rats on a high-fat high-sugar (HFHS) diet not only demonstrated signs of metabolic impairment, but they also developed polycystic ovaries and experienced irregular estrous cycling. Though hyperandrogenism was not characteristic of HFHS animals as a group, elevated testosterone levels were predictive of high numbers of ovarian cysts. Alterations in steroidogenesis and folliculogenesis gene expression were also found via RNA sequencing of ovarian tissue. Importantly, the PCOS-like symptoms induced in these rats may share a similar etiology to PCOS in humans. Therefore, this model offers a unique opportunity to study PCOS at its genesis rather than following the development of disease symptoms.
Introduction
Obesity has been linked with impaired reproductive functioning in women. Obese women are more likely than their normal-weight counterparts to experience reproductive problems such as menstrual irregularity and polycystic ovary syndrome (PCOS) [1] . PCOS is the most common endocrine disorder impacting approximately 10% of women at reproductive age [2] , and studies report that 40%-80% of these patients are obese [3] . However, because obesity and PCOS share several comorbidities including insulin resistance and reproductive failure, it remains difficult to determine the degree to which obesity and PCOS interact to produce these conditions.
The clinical diagnosis for PCOS requires the presentation of two of the three key symptoms of (i) hyperandrogenism, (ii) chronic anovulation or oligoovulation, and (iii) polycystic ovaries (PCO) [4] . Additionally, women with PCOS often present with accompanying metabolic symptoms and other clinical features including weight gain, insulin resistance, hyperinsulinemia, hyperlipidemia, and abdominal adiposity [5, 6] . Though it has been suggested that the pathology of PCOS in normal-weight women differs from that in obese women, lean women with PCOS also demonstrate metabolic disturbances including insulin resistance and hyperinsulinemia [7, 8] . Thus, the elevation of insulin levels in obesity seems to play an important role in the pathophysiology of PCOS, with 50%-70% of patients also presenting with insulin resistance [5] . Interestingly, elevated insulin levels increases ovarian androgen production, and thus hyperinsulinemia may contribute to the development of PCOS [9] [10] [11] .
Various methods have been used to induce PCOS in rodents, including pre-and postnatal exposure to androgens, estrogens, aromatase inhibitors, antiprogesterone agents, constant light, and genetic modifications [12, 13] . The majority of animal models induce PCO through exogenous treatments with testosterone, dihydrotestosterone, or with other agents that increase circulating androgens [14] [15] [16] . However, these PCO models fail to address the underlying causes of the disease. Steroid-induced PCO models typically do not induce both the metabolic and reproductive symptoms of the disease, and therefore, they are not entirely reflective of the actual pathology in humans. Furthermore, though these models effectively induce elevated androgen levels, it remains to be understood as to whether hyperandrogenism causes the PCO morphology in the typical pathology of the disease, or if it results secondarily to changes in ovarian morphology resulting from other metabolic disturbances [17, 18] .
While a high-fat diet has been combined with androgen treatments in previous animal models in order to amplify the metabolic effects of the disease [19] [20] [21] [22] , few studies have examined the effects of diet alone on the development of PCOS. In addition to disrupting normal metabolic functioning, high-fat dieting has been shown to impair reproductive health and reduce fertility in rodent subjects [23, 24] . Interestingly, dietary restrictions have been utilized for the treatment of PCOS. Low-calorie, low-fat dieting is an effective therapy for improving the metabolic and ovarian function of obese women with PCOS [25] [26] [27] . Thus, while diet has been implicated in the treatment of PCOS and has been seen to impact the severity of symptoms, few studies have focused on diet alone as an underlying cause of disease.
The current study utilizes a rodent model to assess the relationship between diet-induced obesity and reproductive health. Female rats were fed a high-fat high-sugar (HFHS) diet in order to compound the effects of high caloric intake and induce several features of PCOS. We assessed markers of metabolic and reproductive health to detect any changes resulting from the HFHS diet. In addition, we used RNA sequencing of ovarian tissue to assess changes in the expression of genes involved in steroidogenesis, folliculogenesis, and insulin signaling. We hypothesized that animals on the HFHS diet would experience reproductive impairment as demonstrated through irregular cycling and abnormal ovarian follicle development. Here, we describe a diet-induced rodent model for PCOS that strongly resembles both the metabolic and reproductive phenotypes of the disease.
Methods

Animals
Female Sprague Dawley rats (n = 60; P17) were obtained from Charles River and were housed with mothers until weaning at day 23. At weaning, rats were randomly assigned to either an HFHS (n = 32) or control diet (n = 28) group. The control group had ad libitum access to water and standard rat chow (Envigo-LM-485, 3.1 kcal/g, 17% calories from fat). The HFHS diet group had ad libitum access to water, a 32% sucrose solution, and high-fat chow (Research Diets-D12492, 5.24 kcal/g, 60% of the calories derived from fat). Animals were housed in pairs in a climate-controlled environment with a 12:12 h light:dark cycle (lights on at 8 am). Animals were weighed and handled every other day. All animal procedures were approved for use by the Washington and Lee University Institutional Animal Care and Use Committee (Protocol # NT0717).
Blood sampling and hormonal measurements
Fasting blood glucose and insulin levels were measured after 10 weeks of dieting. Following an overnight fast, a small incision was made at the tip of the tail and a blood sample (∼100 μL) was collected via the tail vein for each rat. Fasting glucose levels were detected using an Accu-Chek Compact Plus meter. Blood for insulin and testosterone were collected in heparinized glass capillaries and then centrifuged for the collection of plasma. Plasma samples were stored at -20
• C until use. Rat insulin (Crystal Chem, 90010) and testosterone (Crystal Chem, 80550) levels were assessed with commercial kits according to the manufacturer's instructions. To assess possible insulin resistance, the HOMA-IR index was calculated using the following equation:
HOMA-IR is a widely used clinical calculation. It has been validated by comparisons to more direct measures of insulin sensitivity such as glucose tolerance testing and glucose clamp [28, 29] .
Estrous cycle monitoring
Estrous cycles were monitored by daily vaginal lavage during weeks 6-10 of the diet. Estrous cycle stages were identified via cytological examination as previously described [30] . Briefly, if leukocytes were a dominant cell type, the sample was identified as diestrus. If nucleated cells were abundant, the sample was considered proestrus. Those samples with a majority of cornified cells were classified as estrus. The duration of each estrous cycle was determined as the number of days between the appearance of each diestrus phase. Animals were identified as demonstrating persistent vaginal cornification (PVC) if smears revealed at least five consecutive days spent in the estrus phase of the cycle. The identification of PVC has been characterized in previous rodent PCO models [31] . To calculate the total time spent in each phase of the cycle, we divided the total number of days spent in each specific phase (proestrus, estrus, or diestrus) by the total duration of the sampling time. Comparisons of the mean fraction of time spent in each phase of the cycle between the two diet groups were evaluated using a Kruskal-Wallis test. Differences were considered significant at P < 0.05.
Ovariectomy and tissue handling
All rats were bilaterally ovariectomized after 11 weeks of diet exposure. Animals were anesthetized with isoflurane, and ovaries were removed through dorsolateral incisions. Upon removal, ovarian tissue was fixed overnight in 4% paraformaldehyde solution and then transferred to 30% sucrose solution in PBS. Ovaries were then cleaned by removing the oviduct and any surrounding adipose tissue, weighed, and embedded in OCT matrix (Fisher; 23-730-571) for storage at -80
• C until cryostat sectioning.
Ovarian histology and follicular assessment Follicular development was assessed using one ovary from each animal. Ovaries were serially sectioned into 10 μm thick sections, with every fifth section collected on gelatinized glass slides. Histological examination of tissue sections was conducted following hematoxylin and eosin staining. The total numbers of cysts and corpora lutea follicle types for each animal were identified according to criteria as previously described [31] [32] [33] . Briefly, cysts were identified as those follicles displaying a large antral space lacking an ovum and surrounded by an enlarged and densely stained thecal cell layer. An antral or precystic atretic follicle did not qualify as a cyst if the absence of an ovum was limited to only one slide containing the follicle section. As such, the absence of the ovum was necessary in all histological sections in order to classify the follicle as a cyst. Many atretic antral follicles displayed precystic characteristics, but the presence of intact granulosa cell layers meant that these follicles were not counted as cysts. Thus, cysts were differentiated from antral and other precystic atretic follicles based on the characteristics of the granulosa cell layers, with cysts displaying few to no viable granulosa cells within the antral space. Corpora lutea were identified according to tissue density and the presence of a grainy luteinized cell appearance. Corpora lutea were counted only when they exhibited more than a 60% area with higher tissue density. The number of follicles per ovarian tissue section was quantified by dividing the total number count of the follicular structure by the number of tissue sections for that ovary.
Statistical analysis of histological and physiological measurements
For comparisons between groups, all results are expressed as the mean (±SEM). The comparison of means between two groups was evaluated using a Student t-test. Differences were considered significant at P < 0.05. The significance of all correlations was assessed using Pearson correlations and linear regression analysis.
RNA purification, RNA-Seq, and RT-qPCR
At the time of ovariectomy, tissue used for RNA-Seq and RT-qPCR analysis was flash frozen on liquid nitrogen and stored at -80 • C. To purify total RNA, tissue was thawed in TRIzol and homogenized using mechanical disruption. RNA was then purified using a commercial spin column kit with an in-column DNAse digestion, according to the manufacturer's instructions (Direct-zol RNA MiniPrep, Zymo Research R2053), and flash frozen on liquid nitrogen. Ovaries used for RNA-Seq analysis were selected based on terminal weight data, using animals with weights close to the median for their respective experimental groups. Following poly(A) selection, complementary DNA (cDNA) sequencing libraries were prepared using the HiSeq SBS kit (v. 4) with 4x mutiplexing and the quality was verified by Bioanalyzer analysis. Sequencing was performed on the HiSeq 2500 platform, in paired-end 125 base-pair mode. All four independent ovary samples were run in a single lane, which generated a total of 47,664 Mbp of sequence across 1.9 × 10 8 clusters with mean Q-scores all above 35. For RT-qPCR analysis, first-strand cDNA synthesis was performed using a standard reverse transcription reaction (Promega GoScript RT, A5001) with an oligo(dT) 15 primer. Complementary DNA was then purified using a commercial spin column kit (Zymo Research, D4014) to quantify yield and calculate conversion efficiency; subsequent qPCR analysis was performed only on samples showing ≥ 50% poly(A) RNA conversion efficiency. Changes in gene expression were then quantified by qPCR using SYBR green detection (Bio-Rad, 1725272) with internal normalization to an actin control ( Cq method). Primer sequences for target genes and the actin control are available in Supplemental Table S1 .
Read alignment and expression profiling
Raw sequencing reads were filtered for quality and adapter sequences removed using Trimmomatic (v. 0.35) with the following parameters: a four-base sliding window with average quality cutoff of 20, removal of 15 leading and trailing low-quality bases, and a minimum read length of 119 bases [34] . Surviving reads were then aligned to the Rattus norvegicus genome (assembly Rnor 6.0) [35] using the STAR aligner (v. 2.5.1) running in paired-end mode (Supplemental Figure S1 ) [36] . Following read alignment, gene expression estimation for individual samples was performed using RSEM, again running in paired-end mode (Supplemental Figure S2A ) [37] . All subsequent analysis was performed in R using custom scripts [38] .
Differential expression and significance analysis was performed using empirical Bayesian methods implemented in the 'EBSeq' Bioconductor package (v. 1.13.0) with standard parameters (Supplemental Figures S2B and S3) [39] . GO term enrichment analysis was performed using the 'goseq' Bioconductor package, using annotations and gene lengths from the Rn6 genome assembly [40] .
Data access and source code
All raw read files (FASTQ) and gene expression count results (FPKM) will be available as of the date of publication through GEO (GSE83220). Additionally, this dataset will be made available through an interactive data viewer that supports downloads of custom subsets of the data, hosted on the companion site: http://rna.wlu.edu/papers. To support emerging reproducible research standards, all source code used in the data analysis pipeline and to generate the figures shown here will also be hosted on this site and licensed under GNU GPLv3.
Results
High-fat high-sugar diet induces weight gain and insulin resistance
To determine the effects of the HFHS diet on weight gain, animals in both groups were weighed twice per week after weaning. At the end of 11 weeks on the diet, HFHS animals (333 ± 6.8 g) weighed significantly more than controls (282.4 ± 3.1 g, Figure 1A ). A significant difference in weight gain between the two groups was achieved by the third week of diet exposure, and HFHS animals continued to gain significantly more weight than controls for the remainder of the study period ( Figure 1B ). Given that hyperinsulinemia is frequently included among the markers of metabolic dysfunction in patients with PCOS, insulin resistance was assessed in all animals. Fasting insulin and glucose levels were measured from blood samples. Animals in the HFHS group had significantly higher fasting insulin and glucose levels than controls (Figure 2A and B) . HFHS animals also exhibited insulin resistance, as indicated by their elevated HOMA-IR scores compared to controls ( Figure 2C ).
High-fat high-sugar diet disrupts reproductive cycling and promotes persistent estrus
In addition to weight gain and metabolic impairment, HFHS animals also showed signs of reproductive dysfunction. The distribution of estrous cycles differed between the two diet groups in terms of the fraction of time spent in proestrus, estrus, and diestrus (χ 2 = 11.62, df = 1, P < 0.003). Animals on the HFHS diet demonstrated irregular estrous cycling and anovulation. Throughout the duration of the estrous cycle monitoring period, HFHS animals (0.293 ± 0.021) on average spent a significantly greater fraction of time than controls (0.246 ± 0.006) in the estrus phase of the cycle ( Figure 3A ). In addition, HFHS diet animals (0.185 ± 0.011) on average spent a significantly decreased fraction of time compared to controls (0.216 ± 0.007) in the proestrus phase of the cycle ( Figure 3B ). There was no difference between the two diet groups in terms of the fraction of total time spent in diestrus ( Figure 3C ).
High-fat high-sugar diet alters ovarian morphology and induces the formation of polycystic ovaries
Because HFHS animals exhibited abnormal estrous cycling, we conducted a histological analysis of ovarian tissue to assess the underlying causes of this reproductive dysfunction. After bilateral ovariectomy, one ovary from each animal was weighed and used for the assessment of follicular development. No difference was found in the ovary weights between the HFHS and control animals ( Figure 4A ). However, when ovarian morphology was considered, the presence of a high number of cysts in HFHS ovaries was correlated (Pearson correlation, r = -0.656, P < 0.01) with a decrease in ovary weight ( Figure 4B ). This trend was not observed with animals on the control diet (not shown). In terms of follicular development, animals on the HFHS diet had significantly elevated ovarian cyst counts compared to controls (2.16 ± 0.56 vs. 0.94 ± 0.11 cysts/section, Figure 5C ). In addition, ovaries from HFHS animals showed significantly reduced corpora lutea formation compared with those from controls (1.52 ± 0.22 vs. 3.14 ± 0.19 corpora lutea/section, Figure 5D ). Testosterone levels are associated with cyst formation
Because hyperandrogenism serves as one of the clinical markers for PCOS, serum blood samples were taken from animals to assess changes in testosterone levels. While differences in ovarian morphology were seen between control and HFHS animals, no difference in serum testosterone levels was found between the two groups (1.851 ± 0.045 ng/mL for HFHS animals vs. 1.760 ± 0.030 ng/mL for controls, Figure 6A ). However, when ovarian morphology was taken into consideration, elevated testosterone levels in individual animals were linearly dependent upon the numbers of ovarian cysts in tissue from HFHS diet animals (Pearson correlation, r = 0.670, P < 0.01, Figure 6B ). This trend was not observed in control animals (not shown).
High-fat high-sugar diet induces global changes in gene expression in ovarian tissue
To investigate the molecular mechanisms underlying the histological and physiological effects of HFHS diet on ovarian tissue, we used RNA-Seq analysis to quantify changes in gene expression induced by our diet model. Total RNA was isolated from ovaries removed from two animals in each experimental group. Following poly(A) selection, libraries from these four samples were sequenced using paired-end 125 bp reads; more than 75 million reads were mapped to the Rn6 genome assembly for each (Supplemental Figures S1 and  S2 ). Clustering normalized read counts for differentially expressed genes across these four samples reveals distinct sets of both up-and downregulated factors ( Figure 7A ). To systematically characterize the genes that are up-and downregulated with the HFHS diet, we used Gene Ontology biological process terms to find categories of factors that are overrepresented in each group ( Figure 7B , Supplemental Table S2 ). In this analysis, we find very little functional overlap between the two groups. The HFHS diet leads to an increase in expression of factors involved in steroid signaling, ovulation, follicle maturation, the inflammatory response, and lipid metabolism. By contrast, the HFHS diet leads to a strong downregulation in DNA replication and mitotic cell cycle control. Gamete generation is the lone biological process that is modestly enriched in both groups. When we investigate the changes in expression levels for individual genes involved in each stage of folliculogenesis, we see modest effects of diet on genes associated with most stages, with one clear exception: Ereg ( Figure 8A, Supplemental Figure S4A ). Ereg, epiregulin, is strongly upregulated by the HFHS diet and is associated with the primary follicle stage. Consistent with our finding that there is no significant difference in circulating testosterone levels between the two diet treatments, we also see very little evidence of an increase in expression levels for factors involved in testosterone biosynthesis ( Figure 8B ). By contrast, however, there is a strong upregulation in key factors involved in estrogen metabolism, such as Ste2 ( Figure 8B, Supplemental S4C) . Finally, although the HFHS diet induced systemic insulin resistance in our model, we do not see any evidence of a change in gene expression levels of the insulin receptor in ovarian tissue, although several downstream targets of insulin signaling are modestly downregulated ( Figure 8C ).
Discussion
PCOS encompasses a complex disorder characterized by both metabolic and reproductive impairments. Patients presenting with PCOS are often overweight, and thus obesity shares several comorbidities with the disease. In addition, diet itself may play an important role in PCOS pathogenesis. This study demonstrates a rodent model for diet-induced obesity resulting in PCOS with both the metabolic and reproductive phenotypes. The criteria for the diagnosis of PCOS require the presence of two out of the three major symptoms: oligoor anovulation, hyperandrogenism, and PCO. In our study, animals on the HFHS diet strongly presented the symptoms of anovulation and PCO. Additionally, with the correlation between testosterone levels and number of ovarian cysts, a role for hyperandrogenism in the pathology of PCOS has been supported by this study. Unlike previous animal models of PCOS that utilize androgen treatment as the primary source of PCOS induction, this study allows for the use of an animal model that more closely resembles the disease etiology in humans. Thus, the current study presents a novel diet-induced model of rodent PCOS with similar features to the disease presentation in humans.
High-fat high-sugar diet animals recapitulate the reproductive phenotypes of polycystic ovary syndrome
The HFHS diet had clear impacts on the reproductive health of animals in the study. During cycle monitoring, HFHS diet animals exhibited abnormal estrous cycling with daily vaginal smears revealing that many of these animals had entered a persistent cornified state. As a result, HFHS animals spent significantly more time than their control counterparts in the estrus phase of the cycle. This anovulatory state of repeated estrus has been previously characterized, with PVC identified as a marker for irregular cycling and anovulation in rodents with PCO [31, 41] . Additionally, HFHS animals spent significantly fewer days in the proestrus phase of the estrous cycle, indicating decreased ovulatory activity in these animals. Furthermore, HFHS diet animals experienced significant morphological changes to their ovaries. Histological analysis revealed the formation of PCO accompanied by reduced corpora lutea formation, thus indicating reduced ovulatory activity. The reduced formation of corpora lutea is consistent with previous rodent PCO models [12, 16] . With the high incidence of cysts and the reduced formation of corpora lutea, it is likely that follicles experienced arrest prior to the antral and ovulatory stages of development [42, 43] . While ovary weights were not different between the two diet groups, the presence of a high number of cysts in tissue from HFHS animals was predictive of a low ovarian weight. This result was unlike findings from previous animal models of PCOS, which showed that ovaries were larger from polycystic animals compared to controls [14, 31] . Overall, not only did the HFHS diet cause animals to enter into irregular and extended cycling patterns characterized by increased days spent in estrus, but it also induced changes to ovarian structure by impacting follicular development.
High-fat high-sugar animals present with metabolic phenotypes associated with polycystic ovary syndrome As expected, animals on the HFHS diet gained more weight than controls and displayed hyperinsulinemia, similarly to the metabolic profiles seen in humans with PCOS. The development of the hyperinsulinemic state is significant in that elevated insulin levels have been previously shown to result in increased androgen production by ovarian theca cells [9] [10] [11] . The presence of elevated intraovarian androgen levels is associated with anovulation [44] , as well as abnormal follicular maturation and the acceleration of follicular atresia in rats [45] . While an excess of androgens promotes the early growth of follicles, it also induces follicular arrest in later stages of development [45] [46] [47] . This intraovarian androgen excess may result from increased insulin signaling due to hyperinsulinemia or from altered steroidogenesis within the ovary. While animals on the HFHS diet developed hyperinsulinemia, no difference was found between diet groups in terms of circulating testosterone levels. This evidence suggests that hyperandrogenism is not necessary for the development of PCO and that elevated testosterone levels may arise as a delayed secondary effect to the development of hyperinsulinemia or later in the disease pathology of diet-induced PCOS. No correlation was found between insulin levels and the number of ovarian cysts, though PCO were found in insulin resistant and hyperinsulinemic HFHS diet animals.
Hyperandrogenism and polycystic ovaries may develop secondarily to diet-induced hyperinsulinemia
In support of the hypothesis that hyperandrogenism develops as a secondary effect in the pathology of PCOS are the findings that all animals exhibiting elevated androgen levels were hyperinsulinemic. Furthermore, the number of ovarian cysts correlated with increased testosterone levels in highly cystic animals, suggesting a possible relationship between the formation of PCO and the development of hyperandrogenemia. With a high incidence of cysts and elevated testosterone levels occurring in insulin-resistant and hyperinsulinemic animals, increased insulin signaling within the ovary may contribute to both the changes in ovarian morphology and the increased ovarian production of androgens [17] . It has been previously demonstrated that insulin acts directly through its own receptor in PCO theca cells to increase androgen production [10, 48] . Though PCOS women may develop an insulin-resistant state, the ovary continues to respond to insulin signaling for the production of androgens [49] . Thus, the elevation of testosterone levels may occur as a result of insulin-induced cyst formation, whereby hyperplasia of thecal cells in the walls of these cysts may increase steroidogenic activity [17, [50] [51] [52] [53] . Though the current study does not provide direct evidence of the causal relationship between hyperandrogenism and cyst development, our results suggest that both cyst formation and hyperandrogenism may arise from the hyperinsulinemic state since all animals presenting with these symptoms exhibited insulin resistance and elevated insulin levels resulting from the HFHS diet. The hyperplasia of thecal cell layers observed in cystic ovaries and the resulting increase in testosterone production in highly cystic animals could be due to the increased availability of insulin for signaling since insulin acts directly through its own receptor to increase androgen production within the ovary [10] . This finding is in line with previous studies showing that insulin may cause or worsen the symptoms seen in PCOS [54] . Furthermore, though hyperandrogenism is often identified as a central feature of the disease, studies show that not all patients with PCOS present with elevated testosterone levels [55, 56] . In fact, the initial Rotterdam diagnostic criteria for PCOS were expanded in 2003 to essentially acknowledge two phenotypes of the disease: (1) ovulatory women with PCO and hyperandrogenism, and (2) oligoovulatory women with PCO but without hyperandrogenism [4, 57] . As a result, four phenotypic subgroups have been identified for the clinical diagnosis of PCOS. The first subgroup includes patients presenting with complete PCOS characterized by the presence of all three symptoms of PCO morphology, anovulatory or irregular cycling, and hyperandrogenism. The remaining three PCOS subgroups are characterized by the absence of one of these symptoms and include non-PCO morphology, ovulatory, and nonhyperandrogenic PCOS [58] . Due to the presence of both anovulatory cycles and PCO morphology in our HFHS diet animals without whole-group differences in testosterone levels, this experimental model of diet-induced PCOS represents the nonhyperandrogenic phenotypic subtype. Though there was no initial elevation of testosterone levels detected in HFHS diet animals, this might be a downstream effect that would have been revealed with a longer diet exposure. Furthermore, hyperandrogenism and complete PCOS may develop secondarily to the advanced formation of cystic ovaries, as only highly cystic animals in this study demonstrated all three phenotypic PCOS symptoms.
Steroidogenesis and folliculogenesis gene expression is altered in diet-induced polycystic ovary syndrome
The alteration of the expression in genes related to the processes of folliculogenesis, steroidogenesis, and insulin signaling within ovarian tissue may explain some of the reproductive phenotypes observed in HFHS diet animals. Systematic analysis revealed that genes involved in ovulation and the primary follicle stage are generally upregulated in the HFHS diet. Specifically, epiregulin (Ereg) which is involved in mediating luteinizing hormone (LH)-induced ovulation is strongly upregulated [59] . Knockout studies in mice have suggested that Ereg plays a key role in maturation of follicles in the primary follicle stage [60, 61] . Our findings suggest that, at the level of transcriptional program, HFHS diet leads to a protracted primary follicle stage, which is consistent with previously proposed models of PCOS [43, 50, 62] . This model would also be consistent with the strong downregulation we see in factors involved in DNA replication and progression through the mitotic cell cycle.
Steroidogenesis within the ovary is also altered by the HFHS diet. Although we find no strong evidence for a change in testosterone biosynthesis per se, factors involved in testosterone signaling are altered. For example, Cbr1, a factor involved in the follicular synthesis and steroid response pathways, was upregulated [63] . We see much stronger effects on expression of genes involved in estrogen metabolism. For example, Ste2 is among the genes most strongly induced by HFHS diet. Ste2 is necessary for the production of 17alpha,20beta-dihydroxypregn-4-en-3-one (17,20β-P), which has been shown to be involved in oocyte maturation in other vertebrate species [63, 64] . By contrast, the estrogen receptor Esr2 and downstream signaling targets are modestly downregulated. One important caveat to note with respect to the RNA-Seq analysis in this study is that gene expression was quantified using whole-tissue RNA isolation, meaning that specific changes in gene expression cannot yet be ascribed to unique cell populations. Further investigation into both the timing and localization of changes in gene expression in this model of PCOS will be an interesting future area of study.
Finally, while HFHS diet animals became insulin resistant, RNA sequencing revealed normal expression of the insulin receptor. Interestingly, we see upregulation in the insulin receptor-related receptor transcript, Insrr [65, 66] . Although the exact role for this receptor remains unclear, it has been shown to be induced in the thecal cell layer following the LH surge [67] . Although levels of the insulin receptor itself remain constant across the diet treatment, downstream signaling targets such as PI-3K and Akt are modestly downregulated.
Conclusion
Here, we present a rodent model for PCOS that exhibits several features of human PCOS. Our rat model is novel in that it induces many of the symptoms of PCOS with the use of a HFHS diet rather than exogenous hormonal treatments or by altering steroidogenesis pathways. The HFHS diet led to metabolic disturbances as well as impaired reproductive health marked by abnormal cycling and the formation of PCO. Thus, our model offers a unique opportunity to examine the morphological, physiological, and gene expression changes related to PCOS that occur in the rat ovary when exposed to an HFHS diet. In providing evidence that PCOS can be diet induced, results from this study may lead to the eventual tracing of PCOS to its root cause and allow for the early treatment of the syndrome.
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Supplemental Figure S1 . RNA-Seq read alignments. (A) Input and mapped read counts, following quality filtering and alignment to the Rn6 genome assembly using the STAR aligner. Supplemental Figure S4 . RT-qPCR validation of key findings from RNA-Seq. RT-qPCR was performed to independently validate gene expression changes in HFHS ovary tissue described by RNA-Seq analysis for three upregulated (A-C) and one downregulated factors (D). For each target, expression levels were quantified by normalization to a beta-actin control ( Cq method). (A-D) Numbers of biological replicate samples are given above each bar, with three technical performed for each; error bars show the standard error of the mean for biological variation. As predicted by the variability in histological sections, there is a clear bimodality in the transcriptional response to HFHS diet for the upregulated factors (A-C).
Supplemental Table S1 . RT-qPCR primer sequences. Supplemental Table S2 . DE genes symbols (upregulated and downregulated).
